Loading insider details...
Beta
Latest Form 4 (Dec 8, 2025): Grant/Award of 400,000 CRVS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 8, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 400,000 | n/a |
| Jun 6, 2025 | Corvus Pharmaceuticals, Inc. (CRVS) | Exercise/Conversion | 19,357 | $67.7K |
| Dec 23, 2024 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 300,000 | n/a |
| May 7, 2024 | Corvus Pharmaceuticals, Inc. (CRVS) | Purchase | 20,000 | $34.6K |
| Dec 8, 2023 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 200,000 | n/a |
| Dec 20, 2022 | Corvus Pharmaceuticals, Inc. (CRVS) | Purchase | 20,000 | $15.8K |
| Aug 15, 2022 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 160,000 | n/a |
| Sep 13, 2021 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 160,000 | n/a |
| Dec 17, 2020 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 160,000 | n/a |